Net Income (Loss) Attributable to Parent in USD of CorMedix Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CorMedix Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • CorMedix Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $109M.
  • CorMedix Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $162M.
  • CorMedix Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$17.9M, a 61.3% increase from 2023.
  • CorMedix Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$46.3M, a 56% decline from 2022.
  • CorMedix Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.7M, a 5.29% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

CorMedix Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $162M $109M +$111M 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $51.2M $19.8M +$34M 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $17.2M $20.6M +$35.1M 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 -$17.9M $13.5M +$28.2M 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025
Q3 2024 -$46.1M -$2.78M +$6.97M +71.5% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$53.1M -$14.2M -$2.88M -25.5% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$50.2M -$14.5M -$3.9M -36.9% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 -$46.3M -$14.8M -$6.55M -79.7% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 -$39.8M -$9.74M -$2.89M -42.2% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 -$36.9M -$11.3M -$3.67M -48.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$33.2M -$10.6M -$3.53M -50.2% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$29.7M -$8.21M -$418K -5.37% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024
Q3 2022 -$29.3M -$6.85M +$1.72M +20% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$31M -$7.6M -$2.97M -64.1% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$28M -$7.03M +$183K +2.53% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$28.2M -$7.79M -$1.7M -28% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$26.5M -$8.57M -$1.97M -29.8% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$24.5M -$4.63M -$851K -22.5% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$23.7M -$7.22M -$1.66M -29.9% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$22M -$6.09M -$783K -14.8% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 -$21.2M -$6.6M -$1.34M -25.4% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$19.9M -$3.78M -$3.09M -443% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$16.8M -$5.56M -$390K -7.54% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$16.4M -$5.3M -$7.45M -347% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 -$8.98M -$5.26M +$4.97M +48.6% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$14M -$696K +$7.86M +91.9% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$21.8M -$5.17M +$5.02M +49.3% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$26.8M $2.15M +$12.5M 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$39.3M -$10.2M -$280K -2.81% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$39M -$8.56M -$3.41M -66.3% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$35.6M -$10.2M -$2.59M -34.1% 01 Jan 2018 31 Mar 2018 10-Q 14 Aug 2019
Q4 2017 -$33M -$10.3M -$3.91M -61.1% 01 Oct 2017 31 Dec 2017 10-K 29 May 2019
Q3 2017 -$29.1M -$9.96M -$830K -9.1% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$28.3M -$5.15M -$259K -5.31% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$28M -$7.6M -$3.48M -84.5% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$24.5M -$6.4M -$6.4M 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2017
Q3 2016 -$18.1M -$9.13M -$9.12M 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$9.01M -$4.89M -$4.88M 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 -$4.13M -$4.12M -$4.11M 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$18.2K -$3.87K* +$2.21M 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 -$2.23M -$4.69K* +$5.03M 01 Jul 2015 30 Sep 2015 10-K 16 Mar 2017
Q2 2015 -$7.26M -$4.14K* -$3.51M 01 Apr 2015 30 Jun 2015 10-K 16 Mar 2017
Q1 2015 -$3.75M -$5.5K* +$16.7M 01 Jan 2015 31 Mar 2015 10-K 16 Mar 2017
Q4 2014 -$20.5M -$2.21M +$1.22M +35.5% 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2017
Q3 2014 -$21.7M -$5.04M -$2.54M -101% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$19.1M $3.51M +$5.46M 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015
Q1 2014 -$24.6M -$16.7M -$15.5M -1240% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q4 2013 -$9.13M -$3.44M -$2.58M -303% 01 Oct 2013 31 Dec 2013 10-K 12 Mar 2015
Q3 2013 -$6.55M -$2.5M -$1.48M -146% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$5.07M -$1.95M -$1.34M -218% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$3.73M -$1.25M -$348K -38.7% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$3.38M -$852K -$1.23M -324% 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 -$2.15M -$1.02M +$1.58M +60.9% 01 Jul 2012 30 Sep 2012 10-Q/A 04 Mar 2014
Q2 2012 -$3.73M -$613K +$1.86M +75.3% 01 Apr 2012 30 Jun 2012 10-Q/A 04 Mar 2014
Q1 2012 -$5.6M -$899K +$1.08M +54.5% 01 Jan 2012 31 Mar 2012 10-Q/A 04 Mar 2014
Q4 2011 -$6.67M $380K 01 Oct 2011 31 Dec 2011 10-K/A 04 Mar 2014
Q3 2011 -$2.6M -$1.21M -86.7% 01 Jul 2011 30 Sep 2011 10-Q/A 27 Mar 2013
Q2 2011 -$2.48M -$1.3M -111% 01 Apr 2011 30 Jun 2011 10-Q/A 06 Sep 2012
Q1 2011 -$1.98M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$1.39M 01 Jul 2010 30 Sep 2010 10-Q 10 Nov 2011
Q2 2010 -$1.17M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

CorMedix Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.9M +$28.4M +61.3% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 -$46.3M -$16.6M -56% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 -$29.7M -$1.49M -5.29% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024
2021 -$28.2M -$6.18M -28.1% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$22M -$5.59M -34% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$16.4M +$10.4M +38.8% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 -$26.8M +$6.18M +18.7% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 -$33M -$8.37M -33.9% 01 Jan 2017 31 Dec 2017 10-K 29 May 2019
2016 -$24.6M -$6.46M -35.5% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018
2015 -$18.2M +$2.27M +11.1% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017
2014 -$20.5M -$11.3M -124% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017
2013 -$9.13M -$5.75M -170% 01 Jan 2013 31 Dec 2013 10-K 12 Mar 2015
2012 -$3.38M +$3.29M +49.3% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
2011 -$6.67M +$4.23M +38.8% 01 Jan 2011 31 Dec 2011 10-K/A 04 Mar 2014
2010 -$10.9M 01 Jan 2010 31 Dec 2010 10-K 27 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.